| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |